Both in Pharmaceuticals
GT Biopharma vs Curanex Pharmaceuticals
Over the past year GTBP returned −68.7% and CURX returned −51.7%; their daily moves had a correlation of 0.02.
GTBP −68.7% CURX −51.7%Growth of $1, one year, split-adjusted
| Metric | GTBP | CURX |
|---|---|---|
| Price | $4.84 | $5.80 |
| Market cap | $8.7M | $9.1M |
| Today | −8.16% | −6.30% |
| 1 month | −24.0% | +16.2% |
| 6 months | −51.9% | −17.7% |
| Year to date | −75.3% | −12.3% |
| 1 year | −68.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $2.9M |
| Dividend yield | — | — |
| Volatility (60d) | 958.4% | 905.2% |
| Short % of float | 24.1% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).